Your browser doesn't support javascript.
loading
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.
Vahdat, Linda T; Layman, Rachel; Yardley, Denise A; Gradishar, William; Salkeni, Mohamad A; Joy, Anil; Garcia, Agustin A; Ward, Patrick; Khatcheressian, James; Sparano, Joseph; Rodriguez, Gladys; Tang, Shande; Gao, Ling; Dalal, Rita P; Kauh, John; Miller, Kathy.
Afiliación
  • Vahdat LT; Weill Cornell Breast Center, Weill Cornell Medicine, New York, New York, USA ltv2001@med.cornell.edu.
  • Layman R; Ohio State University, Columbus, Ohio, USA.
  • Yardley DA; Tennessee Oncology, Nashville, Tennessee, USA.
  • Gradishar W; Northwestern University Feinburg School of Medicine, Chicago, Illinois, USA.
  • Salkeni MA; Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia, USA.
  • Joy AA; University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Garcia AA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
  • Ward P; Oncology Hematology Care Incorporated, Cincinnati, Ohio, USA.
  • Khatcheressian J; Virginia Cancer Institute, Richmond, Virginia, USA.
  • Sparano J; Weiler Division, Montefiore Medical Center, Bronx, New York, USA.
  • Rodriguez G; South Texas Oncology and Hematology, San Antonio, Texas, USA.
  • Tang S; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Gao L; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Dalal RP; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Kauh J; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Miller K; Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA.
Oncologist ; 22(3): 245-254, 2017 03.
Article en En | MEDLINE | ID: mdl-28220020
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor 1 de Factores de Crecimiento Endotelial Vascular / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Anticuerpos Monoclonales / Neovascularización Patológica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor 1 de Factores de Crecimiento Endotelial Vascular / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Anticuerpos Monoclonales / Neovascularización Patológica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos